e9Abstracts / Research in Social and Administrative Pharmacy 8 (2012) e1–e66

Introduction: In Thailand, hospital pharmacy services

play the important roles in the government health care

service system. Regarding to the drug system compo-

nents (i.e. drug selection, procurement, distribution,

utilization, and the consumer right), there are several

roles of hospital pharmacists in the consumer protection

aspects. In drug selection process, drug specifications

and cost effectiveness are considered to secure the

efficacy, safety and reasonable price of medicines. For

drug procurement, not only drug purchasing concerning

good quality drug with suitable price but also hospital

drug production which is in hospital formulary. Hospital

drug production is one of the major roles of hospital

pharmacists for a long time. In the past, hospital drug

production is needed in order to support the hospitals

and primary health care facilities to increase the access

of medicine and to save cost. In current time, hospital

drug production is still necessary for patients who have

to use some drug formularies which are not available in

the market called extemporaneous preparations; for

example, Oseltamivir suspension. Intravenous admixture

preparations are needed in regional hospitals as well. In

drug distribution process, transportation, storage and

stock management are concerned to sustain the quality,

no dead stock and no lack of drugs for dispense. For

drug use process, out and in-patient drug dispensing

with proper information is done. Moreover, Thai

hospital pharmacists are also responsible for the drug

use in the community. Those are all the hospital

pharmacists’ role related to consumer protection in

the government hospitals.

Aims of the Workshop: The workshop is intended to

demonstrate the pharmacists’ role related to the con-

sumer protection aspects in the government hospital, to

share the practice experiences in the hospital pharmacy

services and pharmacist’s roles regarding drug system

component, to propose the future role of hospital

pharmacy in health consumer protection, and to dem-

onstrate Thai government hospital pharmacy activities

and pharmacist’s role relating to consumer protection

aspects.

Learning Objectives: Participants are to explain how

hospital pharmacists work on the consumer protection

aspects, to describe the Thai hospital pharmacy services

in various levels of hospitals in consumer protection

aspects and to discuss the future role of hospital

pharmacists in consumer protection.

Description of Workshop Activities:

� Presentation: the concept of consumer protection in

hospital pharmacy services

� Demonstration: Thai government hospital phar-

macy services and pharmacist roles in consumer pro-

tection aspect in facilities

� Discussion: the experiences of participants in their

practices

� Discussion: the pharmacist’s role in hospital phar-

macy practices in individual’s context and propose

the key hospital pharmacy activity should be done

for consumer protection in the future

Community Pharmacy Practice in Thailand: TheDiversity of PracticeK. Yotsombut, T. Pengsuparp, S. Palapinyo, Faculty

of Pharmaceutical Sciences, Chulalongkorn University,

Bangkok, Thailand

Introduction: Community pharmacy is a primary unit of

the health care system in Thailand, which mainly provides

self-medications and health care products. Other conven-

tional roles of Thai community pharmacists include: 1)

dispensing the prescribed medications and refilling the

prescription; 2) patient counseling anddrug use education;

and 3) dispensing medications for minor illnesses and

referral for potential serious or emergency problems.

These conventional roles are quite similar to those in

other countries, except for the latter one that Thai

community pharmacists play a crucial role as the general

practitioner. This difference is rooted by unique Thai laws

and regulations that allow us to dispense most of

medications without doctor’s prescription, lead to a wide

range of practice experience and sometimes may cause the

public problems such as inappropriate use of antibiotics

and other medication classes. In addition to those

conventional roles, several emerging activities providing

more pharmaceutical care are currently interested in Thai

community pharmacy practice. These include, but not

limit to,medication therapymanagement (MTM), disease

state management, patient medical profiling, family phar-

macy service, individual health promotion and disease

screening, public health promotion and health consumer

protection. These promising roles drive the paradigm shift

of Thai community pharmacy practice from product-

oriented into patient- and public-oriented practice.

Aims of the Workshop:

1. To explore the diversity of community pharmacist

roles.

2. To share real practice experience of community

pharmacists

Learning Objectives:

1. To demonstrate the diverse roles of Thai commu-

nity pharmacists

2. To describe real practice experience of Thai commu-

nity pharmacists

Description of Workshop Activities:

1. Explain some laws and regulations that control or

affect community pharmacy practice in Thailand

2. Demonstrate the conventional and emerging roles

of Thai community pharmacists

3. Discuss the difference in community pharmacist’s

roles of each country

e10 Abstracts / Research in Social and Administrative Pharmacy 8 (2012) e1–e66

4. Share the experiences of participants into their

practice

5. Conclude the general pharmacist’s roles both in

conventional and emerging activities

SOCIAL PHARMACY WORKSHOP 4: NEW ANDEMERGING ROLES AND RESEARCH

Perceived Barriers to Social Pharmacy ResearchW. Winit-Watjana1, 1Department of Pharmacy, Health

and Well-being, Faculty of Applied Sciences, University of

Sunderland, UK

Introduction: Social pharmacy (SP), which is widely

known as “social and administrative pharmacy” (SAP),

has been established in Scandinavian countries and the

US over the past 40 years. The concepts of SP have also

been widely adopted by pharmacy researchers in many

countries. In the UK and some commonwealth coun-

tries, SP may however be subsumed within the term

“pharmacy practice”. According to research journals

and meetings, SP issues in recent years include health-

care reforms, patients and drug safety, pharmacoeco-

nomics and quality of life, public health and information

technology in pharmacy. Although numerous SP crucial

issues have been addressed, there are still some barriers,

together with facilitators, to SP research in terms of

research design, data analysis, funding, costing, ethical

approval and lack of research teams. It is of paramount

importance for researchers to be aware of these barriers

and solutions to the problems so that they can create

more quality SP research and develop collaborative

research in the future.

Aims of the Workshop: This workshop is aimed to

present Top 10 current issues in SP and perceived

barriers to SP research, and to investigate actual barriers

perceived by international audience.

Learning Objectives: Participants should be able to

explain Top 10 current issues in SP and elaborate the

perceived barriers to SP research.

Description of Workshop Activities: The workshop will

last approximately two hours. It will start with a 40-

minute PowerPoint presentation followed by 10 minutes

of questions and answers. This introductory session will

provide participants with a big picture of SP and

research, i.e. SP concepts, Top 10 current issues in SP

and some barriers to SP research. Then all participants

will be asked to complete a self-administered question-

naire for 15 minutes. After that, they will be split into

several focus groups to discuss their barriers to SP

research for 45 minutes. The last 15 minutes will be spent

on the wrap-up summary.

Additional information: A self-completed questionnaire

needs to be provided for all workshop participants. For

the focus group session, a flipchart per group is

required.

How to Improve Dose Administration Aids for AgedCare FacilitiesJ.F.M. Gilmartin1, S.Y. Hussainy1, J.L. Marriott1,1Centre for Medicine Use and Safety, Monash University,

Parkville, Melbourne, Victoria, Australia

Introduction: Our previous research found that 11.6% of

3,959 audited dose administration aids (DAAs) from

49 Australian residential aged care facilities (RACFs)

suffered from incidents. The DAAs included blister packs

and sachets supplied by pharmacies and used formedicine

administration. The top five incident types included:

unsuitable for packing according to pharmaceutical

packing guidelines; addition of a medicine; incorrect

quantity packed and missing or damaged medicines.

This workshop is designed to educate participants on

these incidents and their potential contributing factors.

Additionally, participants will be asked to evaluate and

modify simulated quality improvement initiatives de-

signed to increase the accuracy of and appropriateness

of DAA packing.

Aims of the Workshop: This workshop is aimed to gain

a greater understanding of the problems associated with

DAA preparation and supply to RACFs, to increase

awareness of factors that may hinder or facilitate

accurate and appropriate DAApreparation, and to equip

participants with the knowledge and skills to develop

quality improvement initiatives in their local setting that

are targeted at DAA preparation and supply.

Learning Objectives: At the end of this workshop,

participants should be able to:

1. Outline the common types of incidents that may oc-

cur in DAAs and explain why they may occur

2. Outline possible quality improvement strategies to

prevent DAA incidents from occurring and explain

their benefits to pharmacy and RACFs

3. Evaluate simulated quality improvement initiatives

and suggest methods to overcome barriers to

implementation

Description of Workshop Activities: Participants will:

1. Be informed of DAA incidents that may occur (as

identified through auditing activities) and contribut-

ing factors to incidents (as identified through stake-

holder focus groups) (30 minute PowerPoint)

2. Be presented with simulated quality improvement

initiatives designed to encourage communication

and improve relationships between members of the

aged care health team, as well as assist in incident

notification and checking processes. (15 minute

PowerPoint)